We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

Fund managers haven’t disclosed any holdings of ATXS yet.

ATXS Hedge Fund Activity: Q1 2026 in Review

0 of the 8,132 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q1 2026, worth a combined $0 — down 100% from $738M a quarter earlier.

Sellers outnumbered buyers: 140 funds closed out of ATXS and 0 opened new positions — a net loss of 140 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $84.9M sold.

  • 0 institutional investors held Astria Therapeutics (ATXS) as of Q1 2026, down from 141 in Q4 2025.
  • Funds reported $0 of Astria Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Astria Therapeutics positions in Q1 2026 and 140 closed out, a net change of -140 holders.
  • The largest Astria Therapeutics seller in Q1 2026 was Perceptive Advisors, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2026.